CPRF Year I (up to $40,000)
|
 |
Dr. Florin Dolcos University of Alberta
"The Impact of Emotion on Cognition: fMRI Investigation of Individual Differences in the Neural Correlates of Emotional Processing in Health and Depressed Groups"
view press release
This project is funded in part through the generous support of the Earl and Renee Lyons Endowment Fund Research Award..
|
CPRF Year II (up to $40,000)
|
 |
RBC Foundation Research Award
Dr. Paul Arnold, University of Toronto
"Glutamate Neurotransmission in OCD: Genetic Study of a Candidate Biological System"
view summary
view press release
This project is funded through the generous support of RBC Foundation |
 |
Schizophrenia Research Award
Dr. David Mamo, University of Toronto
"Antipsychotic Polypharmacy in Schizophrenia"
view summary
view press release
This project is funded through the generous support of Schizophrenia Society of Canada.
|
 |
Dr. Erin Michalak, University of British Columbia
"Mood Monitoring as a Moderator of Relapse in Bipolar Disorder"
view summary
view press release |
 |
CIBC World Markets Children's Miracle Award
Dr. Dave Saint-Amour, University of Montreal
"Electrophysiological Assessment of Sensory Integration Autism"
view summary
view press release
This project is funded through the generous support of CIBC World Market's Children's Foundation
|
|
Partnered Awards: Year II (up to $100,000) |
Neurobiology of Psychiatric
Disorders and Addictions Program
These projects are funded jointly in partnership
with the following organizations:
 |
 |
 |
"Partnerships play a key role in CIHR's vision. With our partners we can accelerate the creation of new ideas and their translation into new clinical practices, innovative health policies and successful business ventures. Since 2003, collaborations between CIHR and Canada’s Research-Based Pharmaceutical Companies (Rx&D), the Canadian Psychiatric Research Foundation, CIHR’s Institute of Neurosciences and Mental Health and AstraZeneca have helped support the development of fundamental science essential to understanding and eventually treating numerous psychiatric disorders such as depression, anxiety and schizophrenia."Dr. David Brener
Director of Research Translation Programs
Canadian Institutes of Health Research
Partnered Awards: Year II (up to $100,000)
|
|
 |
Dr. Paul Albert, University of Ottawa
"DNA methylation at a novel functional polymorphism of the serotonin-1A receptor gene promoter."
view press release |
 |
Dr. Diane Cox, University of Alberta
"NPAS3, encoding a brain transcription factor, as a causative gene for schizophrenia."
view press release |
 |
Dr. Steven Robert Laviolette, University of Western Ontario, Schulich School of Medicine
"Neural mechanisms of nicotine addiction and vulnerability: Role of dopamine transmission in the acute versus dependent phases of nicotine exposure."
view summary
view press release
|
|
| |
